Glenmark Pharmaceuticals informs about media release

10 Jan 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1963.05 47.90 (2.50%)
03-Feb-2026 10:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1697.00
Dr. Reddys Lab 1230.55
Cipla 1334.50
Zydus Lifesciences 905.55
Lupin 2169.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×